Review




Structured Review

PeproTech recombinant human egfl7 protein
Recombinant Human Egfl7 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human egfl7 protein/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human egfl7 protein - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

92
Sino Biological exogenous recombinant human
Exogenous Recombinant Human, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exogenous recombinant human/product/Sino Biological
Average 92 stars, based on 1 article reviews
exogenous recombinant human - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

86
Novus Biologicals egfl7 recombinant protein
Egfl7 Recombinant Protein, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/egfl7 recombinant protein/product/Novus Biologicals
Average 86 stars, based on 1 article reviews
egfl7 recombinant protein - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
PeproTech recombinant human egfl7 protein
Recombinant Human Egfl7 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human egfl7 protein/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human egfl7 protein - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

86
Novus Biologicals anti egfl7 antibody
Anti Egfl7 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti egfl7 antibody/product/Novus Biologicals
Average 86 stars, based on 1 article reviews
anti egfl7 antibody - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Novus Biologicals recombinant egfl7
Sample distributions according to location and analysed parameters. <t>(EGFL7:</t> Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).
Recombinant Egfl7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant egfl7/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
recombinant egfl7 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
OriGene recombinant human egfl7
Sample distributions according to location and analysed parameters. <t>(EGFL7:</t> Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).
Recombinant Human Egfl7, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human egfl7/product/OriGene
Average 90 stars, based on 1 article reviews
recombinant human egfl7 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Novus Biologicals h00051162 p01
Sample distributions according to location and analysed parameters. <t>(EGFL7:</t> Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).
H00051162 P01, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h00051162 p01/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
h00051162 p01 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Sample distributions according to location and analysed parameters. (EGFL7: Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).

Journal: Journal of Translational Medicine

Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

doi: 10.1186/s12967-014-0359-y

Figure Lengend Snippet: Sample distributions according to location and analysed parameters. (EGFL7: Epidermal growth factor-like domain 7; miRNA-126: microRNA-126).

Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

Techniques:

Visualisation of EGFL7 and miRNA-126. Representative images of (A) : the intra-tumoural expression of Epidermal Growth Factor-like Domain 7 (EGFL7), by immunohistochemical analysis, showing staining of endothelial cells (ECs, brown) and the corresponding classified image (Ac) demonstrating intense staining of ECs (green) and faint staining (dark green) of myofibroblasts. Only the intense signal was included in the quantitative estimate. (B) The microRNA-126 (miRNA-126) in situ hybridization (ISH) analysis, showing merely exclusive intra-tumoural expression of ECs (blue) and the corresponding classified image (Bc) demonstrating the ECs included in the quantitative estimate (green).

Journal: Journal of Translational Medicine

Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

doi: 10.1186/s12967-014-0359-y

Figure Lengend Snippet: Visualisation of EGFL7 and miRNA-126. Representative images of (A) : the intra-tumoural expression of Epidermal Growth Factor-like Domain 7 (EGFL7), by immunohistochemical analysis, showing staining of endothelial cells (ECs, brown) and the corresponding classified image (Ac) demonstrating intense staining of ECs (green) and faint staining (dark green) of myofibroblasts. Only the intense signal was included in the quantitative estimate. (B) The microRNA-126 (miRNA-126) in situ hybridization (ISH) analysis, showing merely exclusive intra-tumoural expression of ECs (blue) and the corresponding classified image (Bc) demonstrating the ECs included in the quantitative estimate (green).

Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

Techniques: Expressing, Immunohistochemical staining, Staining, In Situ Hybridization

Clinico-pathologic characteristics according to disease stage and relapse (N = 126)

Journal: Journal of Translational Medicine

Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

doi: 10.1186/s12967-014-0359-y

Figure Lengend Snippet: Clinico-pathologic characteristics according to disease stage and relapse (N = 126)

Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

Techniques:

Dot plot illustrating the intra-tumoural expressions of Epidermal Growth Factor-like Domain 7 (EGFL7) in primary tumours according to stage (St.) and relapse free (−R) and relapsed (+R) patients, respectively (N = 123). See Table for statistical differences between the medians (represented by black bars).

Journal: Journal of Translational Medicine

Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

doi: 10.1186/s12967-014-0359-y

Figure Lengend Snippet: Dot plot illustrating the intra-tumoural expressions of Epidermal Growth Factor-like Domain 7 (EGFL7) in primary tumours according to stage (St.) and relapse free (−R) and relapsed (+R) patients, respectively (N = 123). See Table for statistical differences between the medians (represented by black bars).

Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

Techniques:

 Epidermal growth factor-like domain 7   (EGFL7)  and microRNA-126 (miRNA-126) expressions in primary tumours and associated lymph node/distant metastases

Journal: Journal of Translational Medicine

Article Title: Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study

doi: 10.1186/s12967-014-0359-y

Figure Lengend Snippet: Epidermal growth factor-like domain 7 (EGFL7) and microRNA-126 (miRNA-126) expressions in primary tumours and associated lymph node/distant metastases

Article Snippet: 4 μl recombinant EGFL7 (Novus Biologicals H00051162-P01) and 1 μl of the anti-EGFL7 antibody were mixed in 200 μl dilution buffer (Dako EnVision FLEX WASH BUFFER K8007) to give approximately 2.4 μM antigen versus 0.6 μM antibody.

Techniques: